Print ISSN: 2393-9079
Online ISSN: 2393-9087
CODEN : IJPPTK
Indian Journal of Pharmacy and Pharmacology (IJPP) open access, peer-reviewed quarterly journal publishing since 2014 and is published under auspices of the Innovative Education and Scientific Research Foundation (IESRF), aim to uplift researchers, scholars, academicians, and professionals in all academic and scientific disciplines. IESRF is dedicated to the transfer of technology and research by publishing scientific journals, research content, providing professional’s membership, and conducting conferences, seminars, and award programs. With more...Original Article
Author Details :
Volume : 11, Issue : 3, Year : 2024
Article Page : 156-163
https://doi.org/10.18231/j.ijpp.2024.026
Abstract
Introduction: Coronary artery disease (CAD) poses a significant health burden in India, and ST-elevation myocardial infarction (STEMI) is one of its most severe manifestations. The electrical activity is variable during STEMI, which produces dispersion and raises the T Peak-T End (Tp-Te) interval. STEMI is a medical emergency that requires prompt intervention to restore blood flow to the affected part of the heart muscle. Timely diagnosis and treatment are crucial in reducing morbidity and mortality associated with STEMI. Despite advancements in medical care, access to timely intervention and appropriate healthcare facilities remains a challenge in many parts of India, especially in rural areas.
Materials and Methods: This single-center, prospective observational study included 150 STEMI patients. Clinical, demographic, and ECG data were recorded. The Tp-Te interval alterations and their relationship to major adverse cardiovascular events (MACE) in STEMI patients both during and after successful or unsuccessful fibrinolysis were examined.
Results: Patients without MACE had a significant mean decrease in the Tp-Te interval following successful fibrinolysis (i.e., 18.47 ± 5.66 ms vs. 10 ± 7.07 ms, p:0.039) compared to patients with MACE. It was found that after fibrinolysis, patients with a Tp-Te interval > 100 ms experienced much higher rates of death (4% vs. 0%, p:0.0001), arrhythmias (7.3% vs. 0.7%, p:0.0001), and heart failure (16% vs. 1.3%, p:0.0001), both while they were in the hospital and within 30 days of the index event.
Conclusion: Our data shows that a decrease in the Tp-Te interval following fibrinolysis lowers the risk of MACE both during hospital stay and within 30 days following the index incident.
Keywords: ST-elevation myocardial infarction, T Peak-T End interval, Major adverse cardiovascular events, Fibrinolytic therapy
How to cite : Goswami S, Mohabansi S L, Tomar A, Tp-Te interval variation and its association with MACE as a metric of effective fibrinolysis in patients with STEMI from East India. Indian J Pharm Pharmacol 2024;11(3):156-163
This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.